Clinical Trials Logo
  1. Home
  2. Obstructive Sleep Apnea
  3. NCT04572269

Metabolomics of Obstructive Sleep Apnea — MOSA  

Obstructive Sleep Apnea Clinical Trial

Official title:
Metabolomics of Obstructive Sleep Apnea

Clinical Trial Summary

This is an R01 funded project that focuses on the utility of metabolomics as a biomarker for OSA. Aims 1 and 3 leverages banked samples previously collected from subjects with and without OSA at the University of Pennsylvania and University of Iceland. Aim 2 is a prospective study that will collect serum samples from OSA subjects at the University of Pennsylvania and the University of Iceland.

Clinical Trial Description

The primary objective of Aim 2 is to conduct a prospective observational study to evaluate the metabolomic changes in response to six months of positive airway pressure (PAP) treatment among OSA patients. Newly diagnosed OSA patients (AHI>5) will undergo additional measurements including: accelerometer x one week (to inform the metabolomics), Type 2 home sleep test (to assist with OSA subtyping), next morning blood draw, 24-hour diet recall (to inform the metabolomics), questionnaires and PVT. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04572269
Study type Observational
Source University of Pennsylvania
Contact Kristie C Nguyen
Phone 215-615-4112
Email kristie.nguyen@pennmedicine.upenn.edu
Status Recruiting
Phase
Start date September 21, 2020
Completion date June 30, 2027
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04547543 - Follow-up of Apneic Patients by Visio-consultation N/A
Recruiting NCT05371509 - Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study N/A
Completed NCT02515357 - Mediterranean Diet/Lifestyle Intervention in Obstructive Sleep Apnea N/A
Recruiting NCT05582070 - Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction N/A
Active, not recruiting NCT03189173 - Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea Phase 2
Completed NCT04084899 - The Effect of CPAP on Lung Hyperinflation in Patients With OSA
Completed NCT03032029 - Registry on the Treatment of Central and Complex Sleep-Disordered Breathing With Adaptive Servo-Ventilation
Recruiting NCT04028011 - Clinical Evaluation of a Wearable Technology for the Diagnosis of Sleep Apnoea
Not yet recruiting NCT06043830 - Managing Opioid Related Sleep Apnea With Acetazolamide Phase 2
Active, not recruiting NCT05253963 - Acute Effect of CPAP on Weight in Patients With Obstructive Sleep Apnea N/A
Not yet recruiting NCT06043440 - Oxygen Therapy in Children and Adolescents With Down Syndrome and Obstructive Sleep Apnea Phase 2
Completed NCT03589417 - Postural Stability, Balance and Fall Risk in Patients With Obstructive Sleep Apnea
Active, not recruiting NCT03868618 - Dual-sided Hypoglossal neRvE stimulAtion for the treatMent of Obstructive Sleep Apnea (DREAM) N/A
Active, not recruiting NCT04335994 - ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing N/A
Withdrawn NCT04063436 - Evaluation of a New Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea N/A
Recruiting NCT05385302 - Sociological Determinants of Positive Airway Pressure Adherence in OSA Patients
Not yet recruiting NCT05914948 - Minimally Invasive Electrical Stimulation Of The Nerve Hypoglossal for the Treatment of Obstructive Sleep Apnea. N/A
Not yet recruiting NCT06047496 - Time Restricted Eating in Sleep Apnea Early Phase 1
Not yet recruiting NCT05986487 - Impact of Sleep-Disordered Breathing Management in Systemic Hypertension Control: METASLEEP Project
Withdrawn NCT04011358 - Retinal Vein Occlusion and Obstructive Sleep Apnea: A Case Control Study N/A